Multibagger Pharma Stock Hit 52-Week High As Board Announces Stock Split From Rs 5 to Rs 2 and Stellar Quarterly Results (Q2FY25) and Half-Yearly Results (H1FY25)
Multibagger Pharma Stock Hit 52-Week High As Board Announces Stock Split From Rs 5 to Rs 2 and Stellar Quarterly Results (Q2FY25) and Half-Yearly Results (H1FY25)

Multibagger Pharma Stock Hit 52-Week High As Board Announces Stock Split From Rs 5 to Rs 2 and Stellar Quarterly Results (Q2FY25) and Half-Yearly Results (H1FY25)

The stock is up by 85 per cent from its 52-week low of Rs 270.05 per share and gave multibagger returns of 1,895 per cent in 5 years.

Kiran Shroff Article rating: 3.9

The stock is up by 85 per cent from its 52-week low of Rs 270.05 per share and gave multibagger returns of 1,895 per cent in 5 years.

Multibagger Pharma Stock To Keep Under Radar As Board Likely To Announce Stock Split
Multibagger Pharma Stock To Keep Under Radar As Board Likely To Announce Stock Split

Multibagger Pharma Stock To Keep Under Radar As Board Likely To Announce Stock Split

The stock is up by 75 per cent from its 52-week low of Rs 270.05 per share and gave multibagger returns of over 1,800 per cent in 5 years.

Kiran Shroff Article rating: 4.1

The stock is up by 75 per cent from its 52-week low of Rs 270.05 per share and gave multibagger returns of over 1,800 per cent in 5 years.

Reliance Infra's Largest Shareholders Sees Its Pharma-Held Small-Cap Stock on the Verge of a Breakout: Could It Mirror Reliance Infra's Move?
Reliance Infra's Largest Shareholders Sees Its Pharma-Held Small-Cap Stock on the Verge of a Breakout: Could It Mirror Reliance Infra's Move?

Reliance Infra's Largest Shareholders Sees Its Pharma-Held Small-Cap Stock on the Verge of a Breakout: Could It Mirror Reliance Infra's Move?

one small-cap pharma stock is on the verge of a multi-month breakout

Karan Dsij Article rating: 4.4

Shares have surged over 15 per cent on Wednesday, putting the stock on the verge of a breakout. Notably, it recorded its highest single-day volume since August 26.

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR